光学基因组图谱市场规模、份额和成长分析（按产品、技术、应用、组件和地区划分）—2026-2033年产业预测

全球光学基因组图谱市场规模预计在 2024 年达到 1.4047 亿美元，从 2025 年的 1.7025 亿美元增长到 2033 年的 7.927 亿美元，在预测期（2026-2033 年）内复合年增长率为 21.2%。

市场趋势表明，随着越来越多的实验室寻求可靠地识别短读定序无法识别的结构变异，对光学基因组图谱（OGM）的需求正在增长。仪器和试剂租赁协议的广泛普及，以及化学和流动池技术的进步提高了通量并降低了每个样本的成本，使得OGM的应用范围显着扩大。供应商正透过自动化、基于云端的分析和标准化报告来优化工作流程，从而提高肿瘤学、骨髓恶性肿瘤、罕见疾病以及细胞和基因治疗品管的可重复性。 OGM的应用正从研究试点阶段转向广泛应用，收入来源也转向耗材、软体和服务。关键趋势包括与次世代定序的整合、人工智慧驱动的变异检测以及集中式分析网路的构建，儘管在资本投资、数据解读和临床检验仍然存在挑战。总而言之，OGM正在成为生物製药和全球实验室营运中增强基因组分析的关键高解析度平台。

全球光学基因组图谱市场驱动因素

随着越来越多的实验室采用无缝整合光学基因组图谱和定序技术的端到端综合流程，全球光学基因组图谱市场正经历显着成长。这种整合利用标准化流程、参考样本和先进的判读规则来应对复杂的基因重排，确保不同实验室获得一致且可重复的结果。大规模队列研究和不断变化的报告要求推动了重复试剂盒的日益普及，同时，基于云端的加速分析也提高了多站点环境下的周转时间和人员效率。这些进步共同促进了基因研究和诊断领域的市场扩张和创新。

限制全球光学基因组图谱市场发展的因素

全球光学基因组图谱市场面临许多挑战，可能阻碍其扩张。对结构变异进行分诊、分类和报告所需的专业知识增加了操作的复杂性，尤其对于小规模的队列而言，分析和品管可能面临许多困难。此外，全面的审核文件要求也增加了营运工作量。缺乏标准化的云端解决方案和完善的标准作业规程 (SOP) 会导致不同站点之间出现不一致，从而限制吞吐量，阻碍研究原型向成熟服务产品的过渡，最终成为市场成长的障碍。

全球光学基因组图谱市场趋势

由于采用混合型光学基因组图谱（OGM）-定序报告方法的进步，全球OGM市场正经历显着成长。这些创新方法透过整合光学图谱和定序技术，实现了全面的基因组表征，从而能够精确检测大规模基因组重排，并识别断点和突变。这一趋势提高了数据分析效率，缩短了审核週期，并促进了肿瘤学、血液学和遗传学等领域的跨学科合作。随着整合流程和标准化报告方法的普及，对OGM解决方案的需求预计将持续成长，进一步塑造基因组分析和个人化医疗的模式。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究

全球光学基因组图谱市场规模（依产品/服务划分）及复合年增长率（2026-2033 年）

• 装置
• 耗材和试剂
• 软体和服务

全球光学基因组图谱市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 结构突变检测
• 基因组组装
• 微生物菌株分型
• 罕见变异的识别

全球光学基因组图谱市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 生物技术和製药公司
• 医院和临床检查室
• 学术机构
• 受託研究机构（CRO）

全球光学基因组图谱市场规模（按组件划分）及复合年增长率（2026-2033 年）

• 硬体
• 软体

全球光学基因组图谱市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Bionano Genomics
• Pacific Biosciences
• Oxford Nanopore Technologies
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Qiagen
• Roche
• Bio-Rad Laboratories
• Revvity（PerkinElmer）
• Cytiva（Danaher）
• 10x Genomics

结论与建议

Global Optical Genome Mapping Market size was valued at USD 140.47 Million in 2024 and is poised to grow from USD 170.25 Million in 2025 to USD 792.7 Million by 2033, growing at a CAGR of 21.2% during the forecast period (2026-2033).

Market insights indicate a growing demand for Optical Genome Mapping (OGM) due to laboratories seeking reliable identification of structural variants that surpass the capabilities of short-read sequencing. Expanded access is evident as instrument placements and reagent-rental agreements become more prevalent, complemented by advancements in chemistry and flow cell technology that enhance throughput while reducing cost per sample. Vendors are optimizing workflows through automation, cloud-based analysis, and standardized reporting, fostering reproducibility across oncology, hematologic malignancies, rare diseases, and cell and gene therapy quality control. Adoption is transitioning from research pilots to widespread application, shifting revenue towards consumables, software, and services. Key trends include the integration of OGM with next-generation sequencing, AI-driven variant calling, and the establishment of centralized analysis networks, despite ongoing challenges in capital investment, data interpretation, and clinical validation. Overall, OGM is emerging as a vital, high-resolution platform enhancing genome analysis for biopharmaceutical and laboratory operations globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Genome Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Genome Mapping Market Segments Analysis

Global Optical Genome Mapping Market is segmented by Product, Technique, End-Use, Component and region. Based on Product, the market is segmented into Instruments, Consumables & Reagents and Software and Services. Based on Technique, the market is segmented into Structural Variant Detection, Genome Assembly, Microbial Strain Typing and Rare Variant Identification. Based on End-Use, the market is segmented into Biotech & Pharma Companies, Hospitals & Clinical Labs, Academic Institutes and Contract Research Organizations (CROs). Based on Component, the market is segmented into Hardware and Software. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Optical Genome Mapping Market

The Global Optical Genome Mapping market is experiencing significant growth due to laboratories adopting comprehensive end-to-end processes that seamlessly combine optical genome mapping with sequencing techniques. This integration addresses complex genetic rearrangements by utilizing standardized pipelines, reference samples, and sophisticated interpretation rules, ensuring consistent and reproducible results across different sites. The increasing utilization of repeat kits, driven by larger cohort sizes and evolving reporting obligations, along with the acceleration of cloud-based analysis, enhances turnaround times and staff efficiency in multi-site settings. These advancements collectively contribute to the market's expansion and innovation in genetic research and diagnostics.

Restraints in the Global Optical Genome Mapping Market

The global optical genome mapping market faces several challenges that can hinder its expansion. The necessity for specialist expertise in the triage, classification, and reporting of structural variants complicates operations, particularly for smaller cohorts that may struggle with analysis and quality control due to steep learning curves. Additionally, the requirement for comprehensive audit documentation adds to the operational workload. Without standardized cloud solutions and well-defined standard operating procedures, inconsistencies across different sites may arise, limiting throughput and impeding the transition from research prototypes to established service offerings, ultimately acting as a barrier to market growth.

Market Trends of the Global Optical Genome Mapping Market

The global Optical Genome Mapping (OGM) market is experiencing significant growth driven by advancements in hybrid OGM-sequencing reporting methods. These innovative approaches facilitate comprehensive genome characterization through the integration of optical mapping and sequencing technologies, allowing for the precise detection of large genomic rearrangements alongside breakpoint and variant identification. This trend enhances data analysis efficiency, reduces review cycles, and promotes interdisciplinary collaboration in fields such as oncology, hematology, and constitutional genetics. As integrated pipelines and harmonized reporting methods become standard, the demand for OGM solutions is poised to rise, further shaping the landscape of genomic analysis and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Optical Genome Mapping Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables & Reagents
• Software and Services

Global Optical Genome Mapping Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Rare Variant Identification

Global Optical Genome Mapping Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Biotech & Pharma Companies
• Hospitals & Clinical Labs
• Academic Institutes
• Contract Research Organizations (CROs)

Global Optical Genome Mapping Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware
• Software

Global Optical Genome Mapping Market Size & CAGR (2026-2033)

• North America (Product & Service, Technique, End-Use, Component)
  • US
  • Canada
• Europe (Product & Service, Technique, End-Use, Component)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Technique, End-Use, Component)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Technique, End-Use, Component)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Technique, End-Use, Component)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bionano Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (PerkinElmer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations